Browse

Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer

DC Field Value Language
dc.contributor.authorChoi, Ji-Yeob-
dc.contributor.authorLee, Kyoung-Mu-
dc.contributor.authorNoh, Dong-Young-
dc.contributor.authorAhn, Sei-Hyun-
dc.contributor.authorLee, Jong-Eun-
dc.contributor.authorHan, Wonshik-
dc.contributor.authorJang, In-Jin-
dc.contributor.authorShin, Sang-Goo-
dc.contributor.authorYoo, Keun-Young-
dc.contributor.authorHayes, Richard B-
dc.contributor.authorKang, Daehee-
dc.date.accessioned2009-11-25T05:11:43Z-
dc.date.available2009-11-25T05:11:43Z-
dc.date.issued2006-07-06-
dc.identifier.citationBreast Cancer Res Treat. 2006 Nov;100(2):213-8. Epub 2006 Jul 4en
dc.identifier.issn0167-6806 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16821086-
dc.identifier.urihttps://hdl.handle.net/10371/15273-
dc.description.abstractThe endothelial cell-specific form of nitric oxide synthase (eNOS) may play an important role in tumor progression via angiogenesis or apoptosis. We studied eNOS -786T > C and 894G > T (Glu298Asp), two functionally significant SNPs, in relation to hazard of breast cancer recurrence or death in 873 women with incident, non-metastatic breast cancer, recruited from two teaching hospitals in Seoul, Korea, 1995-2002. Hazards were estimated by Cox proportional hazard models, in relation to genotype, adjusting for hormone receptor status, lymph node involvement, and tumor size. Women carriers of the eNOS -786C allele had significantly increased hazards of breast cancer recurrence or death, compared with women having the TT genotype (HR = 2.1, 95% CI = 1.03-4.33); risks increased up to 3-fold in ER positive cases (HR = 3.2, 95% CI = 0.95-10.50). The hazard was also increased in eNOS 894T carriers, however, it did not reach statistical significance (HR = 1.8, 95% CI = 0.85-3.93). The combined genotypes containing -786C or 894T was associated with a 2.5-fold risk, compared to the TT-GG genotypes, the most dominant genotype combination (95% CI = 1.29-4.68), with the greatest risks in ER positive cases (HR = 4.9, 95% CI = 1.31-18.36). These results indicate that the eNOS -786C polymorphism, and possibly the 894T polymorphism, are associated with breast cancer recurrence and death, particularly in women with ER positive tumors.en
dc.language.isoenen
dc.publisherSpringer Verlagen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectBreast Neoplasms/chemistry/*genetics/mortalityen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMiddle Ageden
dc.subjectNitric Oxide Synthase Type III/*geneticsen
dc.subject*Polymorphism, Geneticen
dc.subjectReceptors, Estrogen/*analysisen
dc.subjectReceptors, Progesterone/*analysisen
dc.titleGenetic polymorphisms of eNOS, hormone receptor status, and survival of breast canceren
dc.typeArticleen
dc.contributor.AlternativeAuthor최지엽-
dc.contributor.AlternativeAuthor이경무-
dc.contributor.AlternativeAuthor노동영-
dc.contributor.AlternativeAuthor안세현-
dc.contributor.AlternativeAuthor이종은-
dc.contributor.AlternativeAuthor한원식-
dc.contributor.AlternativeAuthor장인진-
dc.contributor.AlternativeAuthor신상구-
dc.contributor.AlternativeAuthor유근영-
dc.contributor.AlternativeAuthor강대희-
dc.identifier.doi10.1007/s10549-006-9245-5-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Surgery (외과학전공)Journal Papers (저널논문_외과학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse